Log In
Print this Print this

Anti-TFPI (NN7415)

  Manage Alerts
Collapse Summary General Information
Company Novo Nordisk A/S
DescriptionTissue factor pathway inhibitor (TFPI) (LACI)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHemophilia
Indication DetailsTreat hemophilia A; Treat hemophilia A or B
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today